You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult acute myeloid leukemia in remission

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • cladribine + homoharringtonine + cytarabine
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023

Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

Not yet recruiting
  • Myeloid Malignancies
  • +3 more
  • (no location specified)
Mar 22, 2023

Adult Acute Myeloid Leukemia in Remission Trial in Bologna (Alloreactive NK cell infusion)

Recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • Alloreactive NK cell infusion
  • Bologna, BO, Italy
    Antonio Curti
Jan 18, 2021

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Miami, Florida
    University of Miami
Dec 22, 2022

Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Active, not recruiting
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +9 more
  • Sewell, New Jersey
  • +4 more
Dec 13, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

Completed
Has Results
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 18, 2022

Patients With Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia, Adult
    • Freiburg, CA, Germany
      Medical Center- University of Freiburg
    Aug 4, 2023

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,

    Recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Gemtuzumab Ozogamicin
    • +4 more
    • Baltimore, Maryland
    • +1 more
    Dec 13, 2022

    AML, Adult Trial (STI-8591)

    Not yet recruiting
    • AML, Adult
    • (no location specified)
    Jul 12, 2023

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    AML, Adult Trial in Hangzhou, Shanghai, Wuhan (Selinexor, Azacitidine, Venetoclax)

    Not yet recruiting
    • AML, Adult
    • Hangzhou, China
    • +3 more
    Feb 12, 2023

    Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)

    Not yet recruiting
    • Secondary Acute Myeloid Leukemia
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Mar 22, 2023

    Leukemia, Myeloid, Acute Trial in Seoul (Idarubicin)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Seoul, Korea, Republic of
      Division of Hematology-Oncology, Konkuk University Medical Cente
    Apr 8, 2022

    Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      Sep 22, 2023

      Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)

      Recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Berlin, Germany
      • +9 more
      Jan 13, 2023

      Disease State in Adult Acute Myeloid Leukemia Receiving Oral

      Not yet recruiting
      • Acute Myeloid Leukemia
        • Medellin, Antioquia, Colombia
        • +6 more
        Oct 18, 2022

        Acute Myeloid Leukemia Trial (with or without venetoclax)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • with or without venetoclax
        • (no location specified)
        Apr 29, 2022

        Disease State in Adult Acute Myeloid Leukemia Ineligible for

        Recruiting
        • Acute Myeloid Leukemia
          • Athens, Attiki, Greece
          • +11 more
          Jan 26, 2023

          Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

          Not yet recruiting
          • Leukemia, Myeloid, Acute
          • AML Stage, Adult
          • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
          • Xiamen, Fujian, China
            Bing Xu
          Oct 29, 2022

          Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

          Active, not recruiting
          • Adult Acute Lymphoblastic Leukemia in Remission
          • +46 more
          • Philadelphia, Pennsylvania
            Thomas Jefferson University
          Feb 10, 2021

          Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Oral azacitidine
          • Seoul, Korea, Republic of
            Bristol-Myers Squibb YH
          Oct 3, 2023

          Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

          Terminated
          Has Results
          • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
          • +8 more
          • Duarte, California
            City of Hope Medical Center
          Mar 28, 2022